Annotation Detail

Information
Associated Genes
TOP1
Associated Variants
TOP1 EXPRESSION
TOP1 EXPRESSION
Associated Disease
ovarian cancer
Source Database
CIViC Evidence
Description
Shorter progression free survival was observed in patients with low expression (IHC) of topoisomerase 1 in 16 patients with relapsed or persistent ovarian or peritoneal carcinoma after treatment with topotecan, cyclophosphamide and carboplatin followed by an autologous hematopoietic stem cell transplant.
Variant Origin
N/A
Variant Origin
N/A
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/910
Gene URL
https://civic.genome.wustl.edu/links/genes/5845
Variant URL
https://civic.genome.wustl.edu/links/variants/384
Rating
2
Evidence Type
Predictive
Disease
Ovarian Cancer
Evidence Direction
Supports
Drug
Topotecan,Cyclophosphamide,Carboplatin
Evidence Level
B
Clinical Significance
Sensitivity/Response
Pubmed
19648970
Drugs
Drug NameSensitivitySupported
CarboplatinSensitivitytrue
CyclophosphamideSensitivitytrue
TopotecanSensitivitytrue